258 related articles for article (PubMed ID: 9504682)
1. Premalignant and malignant disease of the breast: the roles of the pathologist.
Page DL; Jensen RA; Simpson JF
Mod Pathol; 1998 Feb; 11(2):120-8. PubMed ID: 9504682
[TBL] [Abstract][Full Text] [Related]
2. [Differential atypical ductal hyperplasia/DCIS/invasive carcinoma diagnosis and significance of micrometastases].
Stosiek P
Zentralbl Chir; 1998; 123 Suppl 5():13. PubMed ID: 10063563
[TBL] [Abstract][Full Text] [Related]
3. The role of pathology in premalignancy and as a guide for treatment and prognosis in breast cancer.
Simpson JF; Page DL
Semin Oncol; 1996 Aug; 23(4):428-35. PubMed ID: 8757269
[TBL] [Abstract][Full Text] [Related]
4. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
[TBL] [Abstract][Full Text] [Related]
5. Current management of ductal carcinoma in situ.
Barth A; Brenner RJ; Giuliano AE
West J Med; 1995 Oct; 163(4):360-6. PubMed ID: 7483593
[TBL] [Abstract][Full Text] [Related]
6. [Atypical ductal and lobular hyperplasia of the breast].
Bricou A; Delpech Y; Barranger E
Gynecol Obstet Fertil; 2009 Oct; 37(10):814-9. PubMed ID: 19766043
[TBL] [Abstract][Full Text] [Related]
7. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
[TBL] [Abstract][Full Text] [Related]
8. Malignant breast lesions that may mimic benign tumors.
Weidner N
Semin Diagn Pathol; 1995 Feb; 12(1):2-13. PubMed ID: 7770672
[TBL] [Abstract][Full Text] [Related]
9. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
Bofin AM; Lydersen S; Hagmar BM
Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
[TBL] [Abstract][Full Text] [Related]
10. Lobular neoplasia: morphology and management.
Jorns J; Sabel MS; Pang JC
Arch Pathol Lab Med; 2014 Oct; 138(10):1344-9. PubMed ID: 25268198
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic problems posed by sub-clinical breast cancers].
Espié M
Contracept Fertil Sex; 1999 Apr; 27(4):298-305. PubMed ID: 10349773
[TBL] [Abstract][Full Text] [Related]
12. [Atypical epithelial hyperplasias, ductal and lobular carcinoma in situ. Treatment, follow-up and prognosis].
Käresen R; Hagen S
Tidsskr Nor Laegeforen; 1987 Mar; 107(9):859-60, 865. PubMed ID: 3035745
[No Abstract] [Full Text] [Related]
13. Contemporary diagnostic approaches for nonpalpable carcinoma of the breast: the role of the radiologist.
Schepps B; Scola FH
R I Med; 1995 Sep; 78(9):239-41. PubMed ID: 7579717
[TBL] [Abstract][Full Text] [Related]
14. [Ductal carcinoma in situ of the breast].
Rueda Domínguez A; Alonso Muñoz MC; Gómez Gómez A; Ojeda González B
Med Clin (Barc); 1993 Oct; 101(14):548-56. PubMed ID: 8231402
[No Abstract] [Full Text] [Related]
15. Expression of tumor-associated antigen (DF3) in atypical hyperplasias and in situ carcinomas of the human breast.
Ohuchi N; Page DL; Merino MJ; Viglione MJ; Kufe DW; Schlom J
J Natl Cancer Inst; 1987 Jul; 79(1):109-17. PubMed ID: 3298784
[TBL] [Abstract][Full Text] [Related]
16. [Standards, Options and Recommendations for the management of ductal carcinoma in situ of the breast (DCIS): update 2004].
Cutuli B; Fourquet A; Luporsi E; Arnould L; Caron Y; Cremoux Pd; Dilhuydy JM; Fondrinier E; Fourme E; Giard-Lefevre S; Blanc-Onfroy ML; Lemanski C; Mauriac L; Sigal-Zafrani B; Tardivon A; This P; Tunon de Lara C; Kirova Y; Fabre N;
Bull Cancer; 2005 Feb; 92(2):155-68. PubMed ID: 15749645
[TBL] [Abstract][Full Text] [Related]
17. Potential role of magnetic resonance imaging and other modalities in ductal carcinoma in situ detection.
Ikeda DM; Birdwell RL; Daniel BL
Magn Reson Imaging Clin N Am; 2001 May; 9(2):345-56, vii. PubMed ID: 11493424
[TBL] [Abstract][Full Text] [Related]
18. [Possibilities and limits of diagnostic frozen section in breast carcinoma].
Guski H; Winzer KJ; Aldinger HU; Frohberg HD; Bick U
Zentralbl Chir; 1998; 123 Suppl 5():19-22. PubMed ID: 10063565
[TBL] [Abstract][Full Text] [Related]
19. Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.
Collins LC; Tamimi RM; Baer HJ; Connolly JL; Colditz GA; Schnitt SJ
Cancer; 2005 May; 103(9):1778-84. PubMed ID: 15770688
[TBL] [Abstract][Full Text] [Related]
20. Lobular carcinoma in situ.
Afonso N; Bouwman D
Eur J Cancer Prev; 2008 Aug; 17(4):312-6. PubMed ID: 18562954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
